A new, fast and reliable radioimmunoassay of brain natriuretic peptide in human plasma. Reference values in healthy subjects and in patients with different diseases

References

• Sudoh T, Kangawa K, Minamino N, Matsuo H. A new natriuretic peptide in porcine brain. Nature 1988; 332: 78–81
   PubMed Web of Science ®Google Scholar
• Togashi K, Kameya T, Ando K, Marumo F, Kawakami M. Brain natriuretic peptides in human plasma, spinal cord and cerebrospinal fluid. Clin Chim Acta 1991; 201: 193–200
   PubMed Web of Science ®Google Scholar
• Mukoyama M, Nakao K, Hosoda K, Suga S, Saito Y, Ogawa Y, et al. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 1991; 87: 1402–12
   PubMed Web of Science ®Google Scholar
• McGregor A, Richards M, Espiner E, Yandle T, Ikram H. Brain natriuretic peptide administered to man: actions and metabolism. J Clin Endocrinol Metab 1990; 70: 1103–7
   PubMed Web of Science ®Google Scholar
• La Villa G, Stefani L, Lazzeri C, Zurli C, Guerra C T, Barletta G, et al. Acute effects of physiological increments of brain natriuretic peptide in humans. Hypertension 1995; 26: 628–33
   PubMedGoogle Scholar
• Okumura K, Yasue H, Fujii H, Kugiyama K, Matsuyama K, Yoshimura M, et al. Effects of brain (B-type) natriuretic peptide on coronary artery diameter and coronary hemodynamic variables in humans: comparison with effects on systemic hemodynamic variables. J Am Coll Cardiol 1995; 25: 342–8
   PubMed Web of Science ®Google Scholar
• Florkowski C M, Richards A M, Espiner E A, Yandle T G, Frampton C. Renal, endocrine, and hemodynamic interactions of atrial and brain natriuretic peptides in normal men. Am J Physiol 1994; 266: R1244–50
   PubMed Web of Science ®Google Scholar
• Holmes S J, Espiner E A, Richards A M, Yandle T G, Frampton C. Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal man. J Clin Endocrinol Metab 1993; 76: 91–6
   PubMed Web of Science ®Google Scholar
• Yoshimura M, Yasue H, Morita E, Sakaino N, Jougasaki M, Kurose M, et al. Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure. Circulation 1991; 84: 1581–8
   PubMed Web of Science ®Google Scholar
• Nakamura S, Naruse M, Naruse K, Kawana M, Nishikawa T, Hosoda S, et al. Atrial natriuretic peptide and brain natriuretic peptide coexist in the secretory granules of human cardiac myocytes. Am J Hypertens 1991; 4: 909–12
   PubMed Web of Science ®Google Scholar
• Pucci A, Wharton J, Arbustini E, Grasso M, Diegoli M, Needleman P, et al. Localization of brain and atrial natriuretic peptide in human and porcine heart. Int J Cardiol 1992; 34: 237–47
   PubMed Web of Science ®Google Scholar
• Yasue H, Yoshimura M, Sumida H, Kikuta K, Kugiyama K, Jougasaki M, et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 1994; 90: 195–203
   PubMed Web of Science ®Google Scholar
• Naruse M, Takeyama Y, Tanabe A, Hiroshige J, Naruse K, Yoshimoto T, et al. Atrial and brain natriuretic peptides in cardiovascular diseases. Hypertension 1994; 23: 1231–4
   Google Scholar
• Buckley M G, Markandu N G, Miller M A, Sagnella G A, MacGregor G A. Plasma concentrations and comparisons of brain and atrial natriuretic peptide in normal subjects and in patients with essential hypertension. J Hum Hypertens 1993; 7: 245–50
   PubMedGoogle Scholar
• Ishizaka Y, Yamamoto Y, Tanaka M, Kato F, Yokota N, Kato J, et al. Molecular forms of human brain natriuretic peptide (BNP) in plasma of patients on hemodialysis (HD). Clin Nephrol 1995; 43: 237–42
   PubMed Web of Science ®Google Scholar
• Wei C M, Heublein D M, Perrella M A, Lerman A, Rodeheffer R J, McGregor C G, et al. Natriuretic peptide system in human heart failure. Circulation 1993; 88: 1004–9
   PubMed Web of Science ®Google Scholar
• Buckley M G, Sethi D, Markandu N D, Sagnella G A, Singer D R, MacGregor G A. Plasma concentrations and comparisons of brain natriuretic peptide and atrial natriuretic peptide in normal subjects, cardiac transplant recipients and patients with dialysis-independent or dialysis-dependent chronic renal failure. Clin Sci Colch 1992; 83: 437–44
   Google Scholar
• Kohno M, Horio T, Yokokawa K, Yasunari K, Ikeda M, Minami M, et al. Brain natriuretic peptide as a marker for hypertensive left ventricular hypertrophy: changes during 1-year antihypertensive therapy with angiotensin-converting enzyme inhibitor. Am J Med 1995; 98: 257–65
   PubMed Web of Science ®Google Scholar
• Lang C C, Motwani J G, Coutie W J, Struthers A D. Clearance of brain natriuretic peptide in patients with chronic heart failure: indirect evidence for a neutral endopeptidase mechanism but against an atrial natriuretic peptide clearance receptor mechanism. Clin Sci Colch 1992; 82: 619–23
   Google Scholar
• Yandle T G, Richards A M, Gilbert A, Fisher S, Holmes S, Espiner E A. Assay of brain natriuretic peptide (BNP) in human plasma: evidence for high molecular weight BNP as a major plasma component in heart failure. J Clin Endocrinol Metab 1993; 76: 832–8
   PubMed Web of Science ®Google Scholar
• Hunt P J, Yandle T G, Nicholls M G, Richards A M, Espiner E A. The amino-terminal portion of probrain natriuretic peptide (Pro-BNP) circulates in human plasma. Biochem Biophys Res Commun 1995; 214: 1175–83
   PubMed Web of Science ®Google Scholar
• Tateyama H, Hino J, Minamino N, Kangawa K, Minamino T, Sakai K, et al. Concentrations and molecular forms of human brain natriuretic peptide in plasma. Biochem Biophys Res Commun 1992; 185: 760–7
   PubMed Web of Science ®Google Scholar
• Rasmussen P H, Bruun N E, Giese J. Comparison of different standards used in radioimmunoassay for atrial natriuretic factor (ANF). Scand J Clin Invest 1991; 51: 533–9
   PubMed Web of Science ®Google Scholar